ASLAN Pharmaceuticals to Participate in Jefferies London Healthcare Conference

Rhea-AI Summary

ASLAN Pharmaceuticals (Nasdaq: ASLN), a biopharmaceutical company focused on immunology, announces participation in the Jefferies London Healthcare Conference from November 15 to 17, 2022. CEO Dr. Carl Firth and CBO Mr. Stephen Doyle will meet with investors at the Waldorf Hilton hotel in London. ASLAN is developing innovative treatments including eblasakimab for atopic dermatitis and farudodstat for autoimmune diseases. For more details, visit www.aslanpharma.com.

SAN MATEO, Calif. and SINGAPORE, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, and Mr Stephen Doyle, CBO will be participating in one-on-one meetings at the Jefferies London Healthcare Conference from November 15 to 17, 2022. The conference will be held in-person at the Waldorf Hilton hotel in London.

Please contact your Jefferies representative to request a one-on-one meeting with management.   

About ASLAN Pharmaceutical

ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating eblasakimab, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and farudodstat, a potent oral inhibitor of the enzyme DHODH, in autoimmune disease. ASLAN has a team in California and in Singapore. For additional information please visit www.aslanpharma.com or follow ASLAN on LinkedIn.

Media and IR contacts

Emma Thompson Spurwing Communications Tel: +65 6206 7350 Email: ASLAN@spurwingcomms.com

Ashley R. Robinson LifeSci Advisors, LLC Tel: +1 (617) 430-7577 Email: arr@lifesciadvisors.com

 

FAQ

Who will represent ASLAN Pharmaceuticals at the Jefferies London Healthcare Conference?

Dr. Carl Firth, CEO, and Mr. Stephen Doyle, CBO will represent ASLAN Pharmaceuticals at the conference.

When is the Jefferies London Healthcare Conference for ASLAN Pharmaceuticals?

The conference will take place from November 15 to 17, 2022.

Where will the Jefferies London Healthcare Conference be held?

The conference will be held at the Waldorf Hilton hotel in London.

What are the innovative treatments being developed by ASLAN Pharmaceuticals?

ASLAN Pharmaceuticals is developing eblasakimab for atopic dermatitis and farudodstat for autoimmune diseases.

How can investors request a meeting with ASLAN Pharmaceuticals management?

Investors can contact their Jefferies representative to request a one-on-one meeting.